Genetic variations in apoptosis pathway and the risk of ovarian cancer

Hui Xie; Wade Tao; Xifeng Wu; Jian Gu

doi:10.18632/oncotarget.10772

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Genetic variations in apoptosis pathway and the risk of ovarian cancer

Hui Xie, Wade Tao, Xifeng Wu and Jian Gu _

PDF | HTML | How to cite

Oncotarget. 2016; 7:56737-56745. https://doi.org/10.18632/oncotarget.10772

Metrics: PDF 1732 views | HTML 2216 views | ?

Abstract

Hui Xie1,2, Wade Tao2, Xifeng Wu2, Jian Gu2

1Department of Breast Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

2Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Correspondence to:

Jian Gu, email: [email protected]

Keywords: single nucleotide polymorphism, apoptosis pathway, ovarian cancer, risk

Received: May 05, 2016 Accepted: June 09, 2016 Published: July 22, 2016

ABSTRACT

Background: Apoptosis is a highly conserved form of cell death and aberrant regulation of apoptotic cell death mechanisms leads to variety of major human diseases, especially tumor formation. Genetic variations in apoptosis genes may increase susceptibility to ovarian cancer.

Results: In individual SNP analysis, 12 SNPs in 5 apoptosis pathway genes were significantly associated with ovarian cancer risk after adjustment for multiple comparisons at q-value <0.05. The most significant SNP was rs11152377 in the Bcl-2 gene. The homozygous variant TT genotype was associated with a significantly decreased risk of ovarian cancer (odds ratio [OR] =0.53; 95% confidence interval [CI], 0.37-0.77, P<0.001). Cumulative effect analysis showed joint effects of increased risk of ovarian cancer with increasing number of unfavorable genotypes in patients. Classification and regression tree (CART) analysis further revealed high-order gene-gene interactions and categorized the study subjects into low-, medium-, and high-risk groups. Compared with the low-risk group, medium-risk group and high-risk group conferred 1.76-fold (95% CI: 1.06–2.90) and 3.64-fold (95% CI: 2.37–5.59) increased risk of ovarian cancer (P for trend <0.001)

Materials and Methods: In a case-control study of 417 ovarian cancer patients and 417 matched controls, we evaluated the associations of 587 single nucleotide polymorphisms (SNPs) from 65 genes of the apoptosis pathway with the risk of ovarian cancer.

Conclusions: Our results suggest that genetic variations in apoptosis pathway genes modulate the risk of ovarian cancer individually and jointly.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 10772

Publication Alerts

Research Papers:

Genetic variations in apoptosis pathway and the risk of ovarian cancer

Abstract